GlassScriptPhysician profile
Raul J Cardenas
NPI 1619187697
$9,951.70
in general payments reported to CMS, 2019-2025
14 companies · $626 in 2025
The $626 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2020: $623 · 2021: $2,915 · 2022: $43.96 · 2023: $3,174 · 2024: $2,214 · 2025: $626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,075 · Food and Beverage: $778 · Travel and Lodging: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,075.00 |
| Food and Beverage | $777.99 |
| Travel and Lodging | $160.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,100.90 | 2021-2025 | Infinity Occipitocervical Upper Thoracic System, Anatomic Peek Ptc Cervical Fusion System, Cd Horizon Spinal System |
| Globus Medical, INC. | $772.23 | 2019-2025 | Senza |
| Medtronic USA, INC. | $206.19 | 2019-2020 | |
| Arthrex, INC. | $204.95 | 2025 | |
| Si-Bone, INC. | $146.61 | 2021 | |
| Centinel Spine, LLC | $102.76 | 2019 | |
| Integrity Implants INC. | $93.92 | 2019 | |
| Amgen INC. | $74.40 | 2024 | Evenity |
| Osteoremedies, LLC | $67.02 | 2023 | Osteoboost Select 10cc |
| Abbvie INC. | $57.00 | 2023-2024 | Ubrelvy, Botox |
| Gentleman Orthopedic Solutions | $40.83 | 2025 | |
| Boston Scientific Corporation | $40.41 | 2022-2024 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $27.00 | 2022-2023 | Proclaim |
| Kuros Biosciences USA, INC | $17.48 | 2025 | Magnetos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raul Cardenas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.